Maven Brands Inc. (C:MJ*CA)
Business Focus: Alternative Medicine
| Sector: Healthcare | Industry: Pharmaceuticals |
| Company Contact | |
| Address: | 100 Kalamalka Lake Road, Unit 32 VERNON BC V1T 9G1 |
| Tel: | N/A |
| Website: | https://mavenbrands.ca |
| IR: | See website |
| Key People | ||
| N/A | ||
| Business Overview |
| Maven Brands Inc. is a Canada-based licensed processor serving the burgeoning craft cannabis community in Canada with a full suite of production, processing, and packaging solutions. The Company, through its subsidiary, Maven Cannabis, owns and operates an approximately 19,500 square foot cannabis facility at the 40-acre Monashee Gateway Business Park, situated in the Village of Lumby at the north end of the Okanagan Valley in the Interior of British Columbia, Canada. Its services include Cannabis production, toll-processing and packaging, regulatory support and QA services, supply contracts for co-branded, nation-wide distribution, small scale microbial and analytics services, genetic cleaning, propagation, cloning and bio-banking services and land packages for new micro sites at Monashee Gateway Business Park. It is also engaged in services program to provide seed-to-shelf solutions for cannabis micro-cultivators and small-scale producers across Canada. |
| Financial Overview |
| For the nine months ended 31 December 2022, Maven Brands Inc revenues decreased from C$6K to C$0K. Net loss decreased 85% to C$292K. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Administrative and office - Balancing va decrease of 56% to C$260K (expense), Wages decrease of 94% to C$18K (expense). |
| Reporting Currency: | Canadian Dollars |
| Enterprise value: | $6.61M as of Dec 31, 2022 |
| Annual revenue (TTM): | $-0.01M as of Dec 31, 2022 |
| EBITDA (TTM): | -$0.72M as of Dec 31, 2022 |
| Net annual income (TTM): | -$0.76M as of Dec 31, 2022 |
| Free cash flow (TTM): | -$0.20M as of Dec 31, 2022 |
| Net Debt Last Fiscal Year: | $5.96M as of Dec 31, 2022 |
| Shares outstanding: | 35,140,866 as of Jan 16, 2023 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.